Edwards Lifesciences Corp. said its 4Q16 revenue will come in at the low end of its $750 million to $790 million guidance range, but strong developments in the company's product pipeline will give it a solid foundation long term. During its annual analyst day, the Irvine, Calif.-based company emphasized that the transcatheter aortic valve replacement (TAVR) market would be at the heart of its plans for the coming year. Analysts seemed to walk away from the event with a highly favorable perspective of the company's general direction.

Wayne, Pa.-based, Teleflex Inc. is set to acquire Minneapolis-based Vascular Solutions Inc. in a transaction valued at about $1 billion. Teleflex's offer of $56 per Vascular Solutions share represents a premium of 1.6 percent to the stock's Thursday close. Upon news of the pending merger, shares of Teleflex (NYSE:TFX) jumped as much as 6.2 percent to $155.09, the biggest intraday percent gain since February. Shares closed at $152.64. Founded in 1997, Vascular Solutions (NASDAQ:VASC) develops clinical solutions for minimally invasive coronary and peripheral vascular procedures. Its product line consists of more than 90 proprietary products...

Wayne, Pa-based, Teleflex Inc. is set to acquire Minneapolis-based Vascular Solutions Inc. in a transaction valued at about $1 billion. Teleflex's offer of $56 per Vascular Solutions share represents a premium of 1.6 percent to the stock's Thursday close. Upon news of the pending merger, shares of Teleflex (NYSE:TFX) jumped as much as 6.2 percent to $155.09, the biggest intraday percent gain since February. Shares closed at $152.64.

Edwards Lifesciences Corp. has agreed to acquire Or Yehuda, Israel-based Valtech Cardio Ltd. for $340 million, with the potential for $350 million in additional milestone payments.

As clinicians become more comfortable with the idea of robots in the care setting, more companies are exploring ways to break into the growing hospital robotics market, which is expected to reach about $11.4 billion by 2020, according to some market researchers. One firm scoping out this space is Equashield LLC with a robot designed to handle hazardous drugs.